Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
V03AC03	DEFERASIROX ARROW	G	Deferasirox - 360mg	360mg	Tablet, coated	13,019,366 L.L
A02BC03	JOSWE LANZOTEC 15	G	Lansoprazole - 15mg	15mg	Capsule	270,112 L.L
A08AB01	ELIZASLIM 120	G	Orlistat - 120mg	120mg	Capsule	1,167,223 L.L
A11CC05	ALTO D 10.000	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	895,895 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 33g/100ml	33g/100ml	Injectable solution	312,577 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
G04BE08	TADALAFIL BIOGARAN	G	Tadalafil - 10mg	10mg	Tablet, coated	1,397,596 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacine (HCl) - 400mg/200ml	400mg/200ml	Injectable solution	9,908,924 L.L
M01AB55	DIFEN PLUS	G	Diclofenac potassium - 50mg, Betamethasone - 0.3mg		Tablet, coated	503,941 L.L
N01BB02	LIDO-CARE	G	Lidocaine - 2%	2%	Injectable solution	100,788 L.L
N03AX11	TOPIRATE 50 BENTA	G	Topiramate - 50mg	50mg	Tablet, film coated	1,407,835 L.L
N05CD08	MIDAZOLAM PANPHARMA	G	Midazolam - 5mg/5ml	5mg/5ml	Injectable solution	697,454 L.L
V03AC03	DEFEROXAL 360	G	Deferasirox - 360mg	360mg	Tablet, film coated	18,834,070 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 10mg	10mg	Tablet, film coated	212,327 L.L
A08AB01	LESSFAT	G	Orlistat - 120mg	120mg	Capsule	391,634 L.L
A11CC05	ALTUM-D3	G	Vitamin D3 - 10,000IU	10,000IU	Capsule	561,342 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 50g/100ml	50g/100ml	Injectable solution	329,815 L.L
C05AX05	PILOCIN	G	Tribenoside - 5%, Lidocaine HCl - 2%		Cream	271,456 L.L
C09CA06	ARKANDA 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	478,664 L.L
C10AA07	APO-ROSUVASTATIN	G	Rosuvastatin (calcium) - 20mg	20mg	Tablet	599,354 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
G04BE08	AMOS	G	Tadalafil - 20mg	20mg	Film, orodispersible	2,175,745 L.L
J01DB04	CEFAZOL IM/IV	G	Cefazolin (sodium) - 1g	1g	Injectable powder	5,375,370 L.L
L02BX03	ABIRATERONE ACETATE NEAPOLIS	G	Abiraterone acetate - 250mg	250mg	Tablet	75,418,662 L.L
M01AB55	DIFEN B12	G	Diclofenac potassium - 50mg, Betamethasone - 0.3mg, Cyanocobalamin - 5mg		Tablet	503,941 L.L
N01BB02	? 2% LIDOCAINE HCL USP	G	Lidocaine HCl - 2%	2%	Injectable solution	255,970 L.L
N03AX11	TORAMAT	G	Topiramate - 50mg	50mg	Tablet, film coated	1,032,071 L.L
N05CD08	HIKMA MIDAZOLAM	G	Midazolam (HCl) - 5mg/ml	5mg/ml	Injectable solution	679,984 L.L
P02CB01	VERMIFUGE	G	Piperazine citrate - 1g/5ml	1g/5ml	Syrup	148,463 L.L